| Identification | Back Directory | [Name]
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | [CAS]
1050477-27-4 | [Synonyms]
(Rac)-Finerenone
(Rac)-BAY 94-8862
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxamide
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl- | [EINECS(EC#)]
810-201-2 | [Molecular Formula]
C21H22N4O3 | [MDL Number]
MFCD32204860 | [MOL File]
1050477-27-4.mol | [Molecular Weight]
378.42 |
| Chemical Properties | Back Directory | [Boiling point ]
554.7±50.0 °C(Predicted) | [density ]
1.29±0.1 g/cm3(Predicted) | [vapor pressure ]
0Pa at 25℃ | [solubility ]
DMSO : 62.5 mg/mL (165.16 mM; Need ultrasonic) | [form ]
Solid | [pka]
14.76±0.40(Predicted) | [color ]
White to off-white | [Water Solubility ]
18.3mg/L at 20℃ | [InChI]
InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26) | [InChIKey]
BTBHLEZXCOBLCY-UHFFFAOYSA-N | [SMILES]
N1C2=C(C(OCC)=NC=C2C)C(C2=CC=C(C#N)C=C2OC)C(C(N)=O)=C1C | [LogP]
2.59 at 25℃ |
| Hazard Information | Back Directory | [Uses]
(Rac)-Finerenone ((Rac)-BAY 94-8862) is the racemate of Finerenone. Finerenone is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist (IC50=18 nM). Finerenone displays excellent selectivity versus glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold)[1]. | [Flammability and Explosibility]
Notclassified | [References]
[1] B?rfacker L, et al. Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases. ChemMedChem. 2012;7(8):1385-1403. DOI:10.1002/cmdc.201200081 |
|
| Company Name: |
DKMbiochem.Co. Ltd
|
| Telephone: |
15901859516 |
| Website: |
http://www.dkmbiochem.com/ |
|